Pieris Pharmaceuticals Insider Trades

PIRS

Track insider trading activity from Pieris Pharmaceuticals executives and directors. See which insiders are buying and selling PIRS stock.

Trades Last 12 Months

PIRS Price

All Insider Trades for Pieris Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Geraghty James A Director
Holding Value $0 0 shares
Last Trade
Dec 12, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$16.1 1 shares
$16.13
$13.60
Holding Value $6.8k 500 shares
Last Trade
Dec 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.22k 500 shares
$16.43
$13.60
Holding Value $1.76M 129,574 shares
Last Trade
Aug 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$47.6k 3,000 shares
$15.88
$13.60
Kiener Peter A Director
Holding Value $544k 40,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4k 40,000 shares
$0.26
$13.60
Barbier Ann Director
Holding Value $544k 40,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4k 40,000 shares
$0.26
$13.60
Said Maya R. Director
Holding Value $544k 40,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4k 40,000 shares
$0.26
$13.60
Richman Michael Director
Holding Value $544k 40,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4k 40,000 shares
$0.26
$13.60
Holding Value $544k 40,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4k 40,000 shares
$0.26
$13.60
Yoder Stephen S. Chief Executive Officer
Holding Value $8.62M 634,021 shares
Last Trade
Feb 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.5M 634,021 shares
$111.20
$13.60
Bures Thomas Chief Financial Officer
Holding Value $3.39M 249,080 shares
Last Trade
Feb 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.7M 249,080 shares
$111.20
$13.60
Kaufmann Hitto Chief Scientific Officer
Holding Value $3.39M 249,080 shares
Last Trade
Feb 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.7M 249,080 shares
$111.20
$13.60
Mousa Ahmed Chief Business Officer
Holding Value $3.39M 249,080 shares
Last Trade
Feb 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.7M 249,080 shares
$111.20
$13.60
Olwill Shane Chief Development Officer
Holding Value $3.39M 249,080 shares
Last Trade
Feb 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.7M 249,080 shares
$111.20
$13.60
Demuth Tim Chief Medical Officer
Holding Value $81.6k 6,000 shares
Last Trade
May 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$821k 6,000 shares
$136.80
$13.60
Holding Value $50M 3,675,530 shares
Last Trade
Jul 21, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$450M 1,900,000 shares
$236.80
$13.60
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.17M 20,000 shares
$258.40
$13.60
Matis Louis Chief Development Officer
Holding Value $1.31M 96,500 shares
Last Trade
Feb 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.9M 96,500 shares
$247.20
$13.60
Reine Allan Chief Financial Officer
Holding Value $2.21M 162,500 shares
Last Trade
Feb 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.2M 162,500 shares
$247.20
$13.60
Prelack Steven Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.38M 20,000 shares
$219.20
$13.60
Holding Value $61.4M 4,511,130 shares
Last Trade
Apr 30, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$504M 989,600 shares
$509.60
$13.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up